Insulin Delivery Devices Market - Global Trends, and Forecast to 2025
Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. In the past, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin infusion(CSII) using an insulin pump and insulin therapy using multiple daily injections (MDI) to more closely match physiologic insulin patterns. Type or dosage of insulin can be changed, to meet the individual needs of the patient. Insulin can be packaged in vials (bottles), cartridges or prefilled pens. The cartridges are used with pen injectors whereas the vials are used with syringes.
Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. In the past, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin infusion(CSII) using an insulin pump and insulin therapy using multiple daily injections (MDI) to more closely match physiologic insulin patterns. Type or dosage of insulin can be changed, to meet the individual needs of the patient. Insulin can be packaged in vials (bottles), cartridges or prefilled pens. The cartridges are used with pen injectors whereas the vials are used with syringes.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
REPORT DESCRIPTION<br />
<strong>Insulin</strong> <strong>Delivery</strong> <strong>Devices</strong> <strong>Market</strong>: Key Players<br />
Major players involved in the global insulin delivery devices market include:<br />
Key players in the market are focusing on developing next generation devices <strong>to</strong> remain competitive, while<br />
seeking ways <strong>to</strong> enhance their design capabilities. For instance, in Oc<strong>to</strong>ber 2017, Eli Lilly <strong>and</strong> Company<br />
announced its plans <strong>to</strong> invest US$ 72 million in an insulin manufacturing project at one of its Indianapolis<br />
facilities. The investment will be used <strong>to</strong> replace an existing insulin vial filling line <strong>and</strong> allow Lilly <strong>to</strong> meet growing<br />
dem<strong>and</strong> for its insulins - including Humalog (insulin lispro) <strong>and</strong> Humulin (human insulin) - while upgrading <strong>to</strong><br />
state-of-the-art technology <strong>and</strong> preparing for its insulin pipeline.<br />
Click here <strong>to</strong> know more about this publish report:<br />
https://www.coherentmarketinsights.com/market-insight/insulin-delivery-devices-market-1352<br />
© Coherent market Insights. All Rights Reserved
Change language